๊ฑฐ๋ž˜์†Œ
์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ
ํƒˆ์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ

Moderna Inc ์ฃผ๊ฐ€
MRNA
#503

โ‚ฉ100,070.83
ย ย 

0.82%

Moderna Inc Info

์‹œ๊ฐ€์ด์•ก
โ‚ฉ39.7T

0.82%

์ผ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰
โ‚ฉ892.23M
์›น์‚ฌ์ดํŠธ
์ž์‚ฐ ์œ ํ˜•
Stock
์ง์›
5800
์„ค๋ฆฝ
Sep 1, 2010
์ฃผ ๊ฑฐ๋ž˜์†Œ
Nasdaq
์‚ฐ์—…
Biological Products, (No Diagnostic Substances)
CIK ๋ฒˆํ˜ธ
0001682852

ํ† ํฐํ™”๋œ ์ฃผ์‹ ๋ฐ์ดํ„ฐ

ํ‰๊ท  ํ† ํฐํ™”๋œ ๊ฐ€๊ฒฉ
โ‚ฉ99.23K
๊ฐ€๊ฒฉ ์ฐจ์ด
+โ‚ฉ832.74(-0.83%)
ํ† ํฐํ™”๋œ ์‹œ์ด
โ‚ฉ92.18M

0.56%

ํ† ํฐํ™”๋œ ๊ฑฐ๋ž˜๋Ÿ‰(24์‹œ๊ฐ„)
โ‚ฉ887.14M

0.63%

๋ฐœํ–‰์ธ
๊ณ„์•ฝ
์ต์Šคํ”Œ๋กœ๋Ÿฌ
MRNA USD ๋ณ€ํ™˜๊ธฐ
MRNA
KRW
๊ฐ€๊ฒฉ ํผํฌ๋จผ์Šค
๋‚ฎ์Œ
โ‚ฉ97.46K
๋†’์Œ
โ‚ฉ101.21K

๋ฐ์ดํ„ฐ ๋กœ๋”ฉ ์ค‘

์ž ์‹œ๋งŒ ๊ธฐ๋‹ค๋ ค ์ฃผ์„ธ์š”, ์ฐจํŠธ ๋ฐ์ดํ„ฐ๋ฅผ ๋กœ๋”ฉํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค

Moderna Inc ์ปค๋ฎค๋‹ˆํ‹ฐ

skeleton-white
ย 
ย 
ย 
ย 
ย 
ย 

About Moderna Inc

What is Moderna Inc?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Inc ๋ผ์ด๋ธŒ ๊ฐ€๊ฒฉ ๋ฐ์ดํ„ฐ

The current price of Moderna Inc in the market is โ‚ฉ100,070.83, with a 24-hour trading volume of โ‚ฉ892.23M. The asset's market cap is โ‚ฉ39.7T, after moving -0.83% in the last day.

Tokenized Moderna Inc is trading at โ‚ฉ99,238.09, with a tokenized market cap of โ‚ฉ92.18M and a 24-hour trading volume of โ‚ฉ887.14M. The tokenized asset has moved 0.57% in the past 24 hours.